Carmen Mesas Vaz, Alba Guembe Mülberger, Marc Torrent Burgas
{"title":"The battle within: how <i>Pseudomonas aeruginosa</i> uses host-pathogen interactions to infect the human lung.","authors":"Carmen Mesas Vaz, Alba Guembe Mülberger, Marc Torrent Burgas","doi":"10.1080/1040841X.2024.2407378","DOIUrl":null,"url":null,"abstract":"<p><p><i>Pseudomonas aeruginosa</i> is a versatile Gram-negative pathogen known for its ability to invade the respiratory tract, particularly in cystic fibrosis patients. This review provides a comprehensive analysis of the multifaceted strategies for colonization, virulence, and immune evasion used by <i>P. aeruginosa</i> to infect the host. We explore the extensive protein arsenal of <i>P. aeruginosa</i>, including adhesins, exotoxins, secreted proteases, and type III and VI secretion effectors, detailing their roles in the infective process. We also address the unique challenge of treating diverse lung conditions that provide a natural niche for <i>P. aeruginosa</i> on the airway surface, with a particular focus in cystic fibrosis. The review also discusses the current limitations in treatment options due to antibiotic resistance and highlights promising future approaches that target host-pathogen protein-protein interactions. These approaches include the development of new antimicrobials, anti-attachment therapies, and quorum-sensing inhibition molecules. In summary, this review aims to provide a holistic understanding of the pathogenesis of <i>P. aeruginosa</i> in the respiratory system, offering insights into the underlying molecular mechanisms and potential therapeutic interventions.</p>","PeriodicalId":10736,"journal":{"name":"Critical Reviews in Microbiology","volume":" ","pages":"1-36"},"PeriodicalIF":6.0000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Reviews in Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/1040841X.2024.2407378","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Pseudomonas aeruginosa is a versatile Gram-negative pathogen known for its ability to invade the respiratory tract, particularly in cystic fibrosis patients. This review provides a comprehensive analysis of the multifaceted strategies for colonization, virulence, and immune evasion used by P. aeruginosa to infect the host. We explore the extensive protein arsenal of P. aeruginosa, including adhesins, exotoxins, secreted proteases, and type III and VI secretion effectors, detailing their roles in the infective process. We also address the unique challenge of treating diverse lung conditions that provide a natural niche for P. aeruginosa on the airway surface, with a particular focus in cystic fibrosis. The review also discusses the current limitations in treatment options due to antibiotic resistance and highlights promising future approaches that target host-pathogen protein-protein interactions. These approaches include the development of new antimicrobials, anti-attachment therapies, and quorum-sensing inhibition molecules. In summary, this review aims to provide a holistic understanding of the pathogenesis of P. aeruginosa in the respiratory system, offering insights into the underlying molecular mechanisms and potential therapeutic interventions.
铜绿假单胞菌是一种多发性革兰氏阴性病原体,以其侵入呼吸道的能力而闻名,尤其是在囊性纤维化患者中。本综述全面分析了铜绿假单胞菌用于感染宿主的定植、毒力和免疫逃避等多方面策略。我们探讨了铜绿假单胞菌广泛的蛋白质库,包括粘附素、外毒素、分泌蛋白酶以及 III 型和 VI 型分泌效应物,详细介绍了它们在感染过程中的作用。我们还探讨了治疗各种肺部疾病所面临的独特挑战,这些疾病为气道表面的铜绿假单胞菌提供了天然的生存环境,其中特别关注囊性纤维化。综述还讨论了目前由于抗生素耐药性而导致的治疗方案的局限性,并重点介绍了针对宿主-病原体蛋白-蛋白相互作用的前景广阔的未来方法。这些方法包括开发新的抗菌剂、抗附着疗法和法定人数感应抑制分子。总之,本综述旨在提供对呼吸系统中铜绿假单胞菌致病机理的整体认识,提供对潜在分子机制和潜在治疗干预措施的见解。
期刊介绍:
Critical Reviews in Microbiology is an international, peer-reviewed journal that publishes comprehensive reviews covering all areas of microbiology relevant to humans and animals, including medical and veterinary microbiology, public health and environmental microbiology. These may include subjects related to microbial molecular biology, immunopathogenicity, physiology, biochemistry, structure, and epidemiology. Of particular interest are reviews covering clinical aspects of bacterial, virological, fungal and parasitic diseases. All reviews must be analytical, comprehensive, and balanced in nature. Editors welcome uninvited submissions, as well as suggested topics for reviews accompanied by an abstract.